Recent evidence also implicates NLRP3 inflammasome-driven neuroinflammation in the pathogenesis of AD, where it promotes both Aβ and tau pathology [88] and triggers the release of IL1β and IL-18 [89]. The gene discussed is MAPT; the disease is Alzheimer disease.